Skip to content
Insilico Medicine logo

Insilico Medicine

AI-driven drug discovery and biomarker development for scalable healthcare innovation

Venture Funded$100M+Series BF-Prime CapitalQiming Venture PartnersEight Roads Ventures
drug discoverybiomarker developmentAI-driven R&Dhealthcare compliance
Share:

About

Insilico Medicine leverages advanced AI to accelerate drug discovery and biomarker development, enabling enterprises to reduce R&D timelines and costs.

This description came from a bulk import and has not yet been checked against the vendor's own page. Treat it as unverified.

Enterprise Readiness

from cataloged data

Not scored. Nobody has checked this entry against Insilico Medicine’s own site yet, so the signals below are unverified and we will not turn them into a rating. The breakdown shows what our record holds.

Security & ComplianceNot disclosed

No compliance certifications listed

Deployment FlexibilityStrong

Flexible deployment: Cloud, Hybrid

Integration DepthStrong

8 documented integrations

Proven AdoptionPartial

5 documented use cases

Company MaturityStrong

Founded 2014 · Series B

Composite of public compliance, deployment, integration, adoption, and company signals. “Not disclosed” reflects gaps in available data, not a vendor deficiency.

Independently sourced

Pulled directly from regulator filings and platform APIs. No vendor or editorial input.

Enterprise Use Cases

AI-powered drug candidate identification
Biomarker discovery for precision medicine
Preclinical trial optimization
Genomic data analysis
Predictive modeling for patient stratification

Integrations

AWSAzureGoogle CloudDataRobotKNIMETableauSnowflakeJupyter

How Insilico Medicine compares

ToolReadinessPricingDeploymentComplianceIntegrations
Insilico MedicineNot scoredEnterpriseCloud, Hybrid8
Aidoc70 · StrongEnterpriseCloud, On-Premise, Hybrid8
EnliticNot scoredEnterpriseCloud, On-Premise, Hybrid6
Babylon HealthNot scoredEnterpriseCloud, Hybrid8

Peers from the same category, ranked by Enterprise Readiness. Readiness is a composite of cataloged compliance, deployment, integration, adoption, and company signals.

Frequently Asked Questions

What is Insilico Medicine used for?

Insilico Medicine is aI-driven drug discovery and biomarker development for scalable healthcare innovation. It is commonly used for ai-powered drug candidate identification, biomarker discovery for precision medicine, preclinical trial optimization, and genomic data analysis.

Is Insilico Medicine free, and how is it priced?

Insilico Medicine uses enterprise pricing, typically a custom quote based on seats, usage, and requirements. Contact the vendor for a quote.

How can Insilico Medicine be deployed?

Insilico Medicine supports Cloud and Hybrid deployment. It is delivered as a cloud-hosted service.

What does Insilico Medicine integrate with?

Insilico Medicine documents 8 integrations, including AWS, Azure, Google Cloud, DataRobot, KNIME, and Tableau.

When was Insilico Medicine founded?

Insilico Medicine was founded in 2014 and has raised $100M+ in funding.

Is Insilico Medicine enterprise-ready?

Based on cataloged data, Insilico Medicine has an Enterprise Readiness score of 62/100 (Established tier), derived from its compliance, deployment, integration, adoption, and company-maturity signals.

Quick Facts

PricingEnterprise
DeploymentCloud, Hybrid
Founded2014
Funding$100M+

Procurement

Evaluating vendors like this one?

The Enterprise AI RFI/RFP asks the security, governance, and lock-in questions sales decks skip.

See the template — RFI $299 / RFP $699

Is this your product?

Claiming is free and lets you correct your listing's data. Upgrade to Enhanced ($199/yr) for a vendor-maintained mark, a richer profile, and lead routing.

·

Alternatives to Insilico Medicine

View all →

Comparable Industry / Vertical AI tools, ranked by enterprise readiness.